Although the scope of the inspection is not clear, hospital regulators have recently been criticized for their lax response to signs of an increase in mortality at the hospital’s heart institute. The hospital stopped all pediatric heart surgeries in October 2018.
A Florida Agency for Health Care Administration spokesperson told the Times that the agency had visited the facility.
A hospital spokesperson confirmed federal inspectors also visited the facility.
“We appreciate the oversight role that our regulators play, and we will, as always, be fully cooperative and collaborative as they conduct any reviews necessary,” a statement from the hospital said.
A CMS spokesperson declined to comment to the Times beyond saying the matter was “an ongoing review.”
In November, the Times found the hospital’s mortality rate for heart surgery patients tripled from 2015 to 2017 to become the highest rate in Florida. The increase occurred after staff members told hospital leaders about issues with two of its heart surgeons, according to the Times.
Baltimore-based Johns Hopkins Medicine, which owns the hospital, recently hired a former federal prosecutor to investigate issues at the facility and a panel of outside experts to help reopen the heart surgery program.
More articles on clinical leadership and infection control:
Patient dies hours after being turned away from Wisconsin hospital
How a Michigan cancer center uses VR to calm chemotherapy patients
Physician monitored for Ebola released from Nebraska Medical Center
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.